HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel lymphocyte transformation test (LTT-MELISA) for Lyme borreliosis.

Abstract
Diagnosis of active Lyme borreliosis (LB) remains a challenge in clinically ambiguous, serologically indeterminant, and polymerase chain reaction-negative patients. Lymphocyte transformation tests (LTTs) have been applied to detect specific cellular immune reactivity, but their clinical application has been severely hampered by the poorly defined Borrelia antigens and nonstandardized LTT formats used. In this study, we describe the development and clinical relevance of a novel LTT using a validated format (MELISA) together with well-defined recombinant Borrelia-specific antigens. From an initial screening of 244 patients with suspected Borrelia infection or disease, 4 informative recombinant antigens were selected: OspC (Borrelia afzelii), p41-1 (Borrelia garinii), p41-2 (B. afzelii), and p100 (B. afzelii). Thereafter, 30 seronegative healthy controls were tested in LTT-MELISA(R) to determine specificity, 68 patients were tested in parallel to determine reproducibility, and 54 lymphocyte-reactive symptomatic patients were tested before and after antibiotic therapy to assess clinical relevance. Most (86.2%) of the 36.9% (90/244) LTT-MELISA positive patients were seropositive and showed symptoms of active LB. Specificity was 96.7% and reproducibility 92.6%. After therapy, most patients (90.7%) showed negative or markedly reduced lymphocyte reactivity correlating with clinical improvement. This novel LTT-MELISA assay appears to correlate with active LB and may have diagnostic relevance in confirming LB in clinically and serologically ambiguous cases.
AuthorsElizabeth Valentine-Thon, Karsten Ilsemann, Martin Sandkamp
JournalDiagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis) Vol. 57 Issue 1 Pg. 27-34 (Jan 2007) ISSN: 0732-8893 [Print] United States
PMID16876371 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Antigens, Bacterial
  • Bacterial Proteins
  • Recombinant Proteins
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Bacterial (immunology)
  • Bacterial Proteins (immunology)
  • Borrelia burgdorferi (immunology)
  • Borrelia burgdorferi Group (immunology)
  • Female
  • Humans
  • Lyme Disease (diagnosis, microbiology)
  • Lymphocyte Activation (immunology)
  • Male
  • Middle Aged
  • Recombinant Proteins (immunology)
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Serologic Tests (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: